Home › Funds › PERCEPTIVE ADVISORS LLC › DBVT

PERCEPTIVE ADVISORS LLC position in DBVT

DBV TECHNOLOGIES S A · Health Care

PERCEPTIVE ADVISORS LLC reported holding 1,653,350 shares of DBVT (DBV TECHNOLOGIES S A) in its Q2 2026 13F filing — a position valued at US$27.1M, representing 0.43% of its reported portfolio and ranking #48 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed DBVT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.65M sh
Reported value held$27.11M
Portfolio Weight0.43%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PERCEPTIVE ADVISORS LLC's DBVT position evolved

PERCEPTIVE ADVISORS LLC first disclosed a stake in DBVT in Q1 2026 at 964,391 shares (US$20.1M). The position peaked in Q2 2026 at 1,653,350 shares, worth US$27.1M. Across 2 filings, PERCEPTIVE ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,653,350 shares valued at US$27.1M — an increase of 688,959 shares quarter over quarter.. Notable position changes include a 71% increase in Q2 2026 (shares fell 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 964.39K $20.15M New
Q2 2026 1.65M $27.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DBVT and 13F data

DBVT (DBV TECHNOLOGIES S A) is a Health Care company. 57 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Siren, L.L.C. (US$30.5M), Vivo Capital, LLC (US$30.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DBVT

All DBVT fund holders →

FAQ

How long has PERCEPTIVE ADVISORS LLC held DBVT?

PERCEPTIVE ADVISORS LLC has disclosed DBVT holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is PERCEPTIVE ADVISORS LLC's current position in DBVT?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 1.65M shares of DBVT (DBV TECHNOLOGIES S A), valued at $27.11M, representing 0.43% of its reported portfolio and ranking #48.

Has PERCEPTIVE ADVISORS LLC been buying or selling DBVT?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in DBVT. The position peaked in Q2 2026 at 1.65M shares.

Which other funds hold DBVT?

Other major institutional holders of DBVT include MPM BioImpact LLC, Siren, L.L.C., Vivo Capital, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.